Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...
PARIS, FRANCE, 14 JANUARY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the presentation of 14 across multiple neurological conditions at the TOXINS 2026 conference (14-17 January) in ...
Animal or in vitro studies, studies performed in pediatric populations, and studies reporting treatment with BoNT products other than onabotulinumtoxinA were excluded. The full-text publications of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results